Revised Immunization Plan for Hepatitis B
Ukraine's Ministry of Health will implement a new national vaccination schedule for hepatitis B starting in 2026. This update is a significant public health measure designed to enhance protection against this serious liver disease. For children without specific risk factors, the new protocol will involve administering doses at 2, 4, 6, and 18 months of age. The vaccine is provided free of charge and is available at all state healthcare facilities and many private clinics that partner with Ukraine's National Health Service.
Vaccine Efficacy and Disease Risks
Hepatitis B is a viral infection that attacks the liver and can lead to severe long-term complications, including cirrhosis and liver cancer. Infants under one year old face the highest risk of infection; if infected at this age, the disease progresses to a chronic state in approximately 90% of cases. For children infected between ages 1 and 6, the risk of chronic infection drops to 30–50%. The hepatitis B vaccine is highly effective, with protection rates exceeding 90%, and immunity from the complete series lasts for a minimum of 30 years. Vaccination is a cornerstone of preventive healthcare globally.
The updated immunization schedule will utilize combination vaccines, such as those protecting against diphtheria, tetanus, pertussis, Haemophilus influenzae type b, and hepatitis B. The hepatitis B virus is transmitted through:
- Mother-to-child transmission during childbirth;
- Exposure to infected blood (via non-sterile medical or cosmetic tools, manicures, or tattoos);
- Close contact through broken skin or mucous membranes.
Symptoms of advanced hepatitis B can include jaundice (yellowing of the skin and eyes), dark urine, and pain in the upper right abdomen.
Parents are urged to note these new guidelines, as immunizing infants is crucial for preventing hepatitis B and its potential future complications. This policy change represents a major advancement in preventing hepatitis B among children in Ukraine. Strengthening immunization coverage is expected to reduce infection rates and improve public health outcomes, particularly for high-risk groups. It is vital for parents to be informed about the updated recommendations and to actively participate in vaccinating their children.